Lobbying client

VYRIPHARM ENTERPRISES, INC.

Scientific research and development

Filings
10
Filed by
1
Reported in-house
—
Reported by firms
$220,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2021 to 2022

Filings

10 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2022
CORNERSTONE GOVERNMENT AFFAIRS, INC. — reported
2nd Quarter - Report
2nd Quarter 2022
CORNERSTONE GOVERNMENT AFFAIRS, INC. — reported
1st Quarter - Report
1st Quarter 2022
CORNERSTONE GOVERNMENT AFFAIRS, INC. $80,000 reported
4th Quarter - Report
4th Quarter 2021
CORNERSTONE GOVERNMENT AFFAIRS, INC. $80,000 reported
3rd Quarter - Amendment
3rd Quarter 2021
CORNERSTONE GOVERNMENT AFFAIRS, INC. $30,000 reported
2nd Quarter - Amendment
2nd Quarter 2021
CORNERSTONE GOVERNMENT AFFAIRS, INC. $30,000 reported
3rd Quarter - Reportreplaced
3rd Quarter 2021
CORNERSTONE GOVERNMENT AFFAIRS, INC. $30,000 reported
2nd Quarter - Reportreplaced
2nd Quarter 2021
CORNERSTONE GOVERNMENT AFFAIRS, INC. $30,000 reported
Registration - Amendment
2nd Quarter 2021
CORNERSTONE GOVERNMENT AFFAIRS, INC. — reported
Registration
2nd Quarter 2021
CORNERSTONE GOVERNMENT AFFAIRS, INC. — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
CORNERSTONE GOVERNMENT AFFAIRS, INC. 6 $220,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Food Industry (safety, labeling, etc.) FOO 8
Health Issues HCR 8
Pharmacy PHA 8

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.